Blog.
Notes on AI, drug discovery, and building platforms in biomedicine. Short posts. No listicles. Occasional diagrams.
2026
AI drug discovery is finally on trial. Both verdicts are already being written.
10 Aug 2026·12 min readRentosertib — AI-discovered target, AI-designed molecule — entered a pivotal Phase III in July. Fifteen to twenty more programs may follow this year. The boosters will over-read a success, the sceptics will over-read a failure, and both will be making the same statistical mistake. A field guide to reading the class of 2026 honestly.
From drug molecule to protocol document: how multi-agent orchestration is reshaping clinical trial design
22 Apr 2026·13 min readThe industry is building point solutions — a simulation tool here, a document drafter there, a sample-size calculator somewhere else. What clinical development actually needs is an end-to-end reasoning system that thinks like the team it replaces. We built one.